Dr Debra Patt Discusses Ongoing Pandemic-Related Delays in Cancer Screenings
Dr. Debra Patt highlights ongoing cancer screening delays from COVID-19, citing reduced capacity and staffing shortages as key challenges.
In a featured segment, Debra Patt, M.D., Ph.D., MBA, Executive Vice President, Public Policy, Payer Relations, and Strategic Initiatives at Texas Oncology, addressed roadblocks to cancer screenings caused by COVID-19 in 2020 and how those challenges continue to reverberate.
Read the full story at American Journal of Managed Care
Read the full story at American Journal of Managed Care